Molecular biology of lentivirus-mediated gene transfer

Current Topics in Microbiology and Immunology

Volumn 261, Issue , 2002, Pages 1-30

  Stevenson, M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; INTEGRASE; LENTIVIRUS VECTOR; MATRIX PROTEIN; VIRUS DNA; VPR PROTEIN;

GENE TRANSFER; LIFE CYCLE; MODEL; MOLECULAR BIOLOGY; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; REVIEW; VIRION; VIRUS CELL INTERACTION; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS REPLICATION;

DNA VIRUSES; LENTIVIRUS;

EID: 0036201681     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-56114-6_1     Document Type: Review

References (187)

1. Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain
2. Alpha interferon-induced antiretroviral activities: Restriction of viral nucleic acid synthesis and progeny virion production in human immunodeficiency virus type 1-infected monocytes
3. Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type I accessory genes vpr, vpu and nef: Mutational analysis of a primary HIV-1 isolate
4. Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral DNAs detected by RNA mobility shift assays
5. Human immunodeficiency virus type 1 Vif-mutant particles from restrictive cells: Role of Vif in correct particle assembly and infectivity
6. Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme
7. Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor
8. A nucleoprotein complex mediates the integration of retroviral DNA
9. CPZ GAB but not group O HIV-1 or other primate immunodeficiency virus
10. Correct integration of retroviral DNA in vitro
11. Retroviral integration: Structure of the initial covalent product and its precursor, and a role for the viral IN protein
12. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1
13. Ultrastructural evidence of an interaction between Env and Gag proteins during assembly of HIV type 1
14. Establishment of a functional reverse transcription complex during HIV-1 entry involves the host cell cytoskeleton
15. Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear of viral DNA
16. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes
17. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection
18. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection
19. Characterization of human immunodeficiency virus type 1 Vif particle incorporation
20. Detection of HTLV-III RNA in lungs of patients with AIDS and pulmonary involvement
21. Identification of HIV-1 vpr product and function
22. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mono-nuclear phagocytes
23. Direct interaction between the envelope and matrix proteins of HIV-1
24. Peripheral blood mononuclear cells produce normal amounts of defective vif-human immunodeficiency virus type 1 particles which are restricted for the prererotranscription steps
25. HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: A further obstacle to eradication
26. Retroviruses as model systems for the study of nuclear RNA export pathways
27. First glimpses as structure-function relationships of the nucleocapsid protein of retroviruses
28. Identification of highly attenuated mutants of simian immunodeficiency virus
29. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions
30. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr
31. Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages
32. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein
33. A novel nuclear export activity in HIV-1 matrix protein required for viral replication
34. Human immunodeficiency virus type 1 in spinal cords of acquired immune deficiency syndrome patients with myelopathy: Expression and replication in macrophages
35. Human immunodeficiency virus integration in a cell-free system
36. HIV-1 regulatory/accessory genes: Keys to unraveling viral and host cell biology
37. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4
38. The core and carboxyl-terminal domains of the intergrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding
39. Integration of human immunodeficiency virus type 1 DNA in vitro
40. Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus
41. The sor gene of HIV-1 is required for efficient virus transmission in vitro
42. SM
43. Structure and function of the nuclear pore complex
44. Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex
45. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins
46. Specific incorporation of cyclophilin A into HIV-1 virions
47. HIV-1: Fifteen proteins and an RNA
48. HIV-1 gag proteins: Diverse functions in the virus life cycle
49. Domains of the human immunodeficiency virus tyupe 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions
50. Integration of mini-retroviral DNA: A cell-free reaction for biochemical analysis of retroviral integration
51. Persistence of HIV-1 transcription in peripheral blood mononuclear cells in patients receiving potent antiretroviral therapy
52. + T lymphocytes
53. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins
54. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway
55. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator
56. Low levels of deoxynucleotides in peripheral blood lymphocytes: A strategy to inhibit human immunodeficiency virus type 1 replication
57. Localization of the amphotropic murine leukemia virus receptor gene to the pericentromeric region of human chromosome 8
58. Virus isolation from and identification of HTLV-III/LAV-pro ducing cells in brain tissue from a patient with AIDS
59. Assembly and morphology of HIV: Potential effects of structure on viral function
60. Construction and in vitro properties of HIV-1 mutants with deletions in nonessential genes
61. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo
62. Role of Vif in human immunodeficiency virus type 1 reverse transcription
63. Identification of domains in the simian immunodeficiency virus matrix protein essential for assembly and envelope glycoprotein incorporation
64. Concerted integration of retrovirus-like DNA by human immuno deficiency virus type 1 integrase
65. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1
66. The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class 1 MHC complexes
67. HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product
68. VPX Mutants of HIV-2 are infectious in established cell lines but display a severe defect in peripheral blood lymphocytes
69. Retroviral cDNA integration: Mechanism, applications and inhibition
70. Human immunodeficiency virus type 2 preintegration complexes: Activities in vitro and response to inhibitors
71. The vif gene is essential for efficient replication of caprine arthritis encephalitis virus in goat synovial membrane cells and affects the late steps of the virus replication cycle
72. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells
73. cdc2 activity
74. Efficient synthesis of viral nucleic acids following monocyte infection by HIV-1
75. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells
76. Spatial visualization of the maturing HIV-1 core and its linkage to the envelope
77. Role of vif during packing of the core of HIV-1
78. Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV
79. Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gpl60 with CD4 blocks the movement and maturation of CD4 to the plasma membrane
80. Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase
81. Tat, Tat-associated kinase, and transcription
82. Multifaceted activities of the HIV-1 transactivator of transcription, Tat
83. Characterization of HIV-1 vpr nuclear import: Analysis of signals and pathways
84. 2+ phase of the cell cycle
85. Analysis of human immunodeficiency virus type 1 LTR-LTR junctions in perioheral blood mononuclear cells of infected individuals
86. Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes
87. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein
88. Vpx association with mature core structures of HIV-2
89. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle
90. Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells
91. Discontinuous plus-strand DNA synthesis in human immunodeficiency virus type 1-infected cells and in a partially reconstituted cell-free system
92. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy
93. gag required for the incorporation of human immunodeficiency virus type 1vpr
94. gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of vpr into heterologous viral particles
95. Progression to the Glb phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells
96. Subcellular localization of avian sarcoma virus and human immunodeficiency virus type integrases
97. Exclusion of HIV coreceptors CXCR4, CCR5, and CCR3 from the HIV envelope
98. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner
99. HIV recent advances in AIDS research: Genetics, molecular biology and immunology [editorial]
100. gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles
101. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules
102. The HIV-1 matrix domain of Gag is required for Vpu responsiveness during particle release
103. HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals
104. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus
105. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures
106. The human immunodeficiency virus type 1 long terminal repeat specifies two different transcriptional complexes, only one of which is regulated by tat
107. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions
108. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein
109. Mutagenesis of the putative α-helical domain of the Vpr protein of human immunodeficiency virus type 1: Effect on stability and virion incorporation
110. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif
111. HIV-1 entry inhibitors: Evading the issue
112. Human immunodeficiency virus type 1 preintegration complexes: Studies of organization and composition
113. Ran and nuclear transport
114. Induction of immediate early response genes by macrophage colony-stimulating factor in normal human monocytes
115. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41
116. The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions
117. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
118. Unintegrated viral DNA as a marker for human immunodeficiency virus 1 infection in vivo and in vitro
119. Characterization of human immunodeficiency virus type 1 matrix revertants: Effects on virus assembly, gag processing, and Env incorporation into virions
120. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly
121. Macrophages as a source of HIV during opportunistic infections
122. Mutational analysis of the hydrophobic tail of the human immunodeficiency virus type 1 p6(Gag) protein produces a mutant that fails to package its envelope protein
123. Intracellular factors involved in gene expression of human retroviruses
124. Lymphoid organs function as major reservoirs for human immunodeficiency virus
125. Unintegrated HIV-1 circular 2-LTR proviral DNA as a marker of recently infected cells: Relative effect of recombinant CD4, zidovudine, and saquinavir in vitro
126. 2-LTR circular viral DNA as a marker for human immunodeficiency virus type 1 infection in vivo
127. Incorporation of Vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region of gag and mutational analysis
128. Oliogmerization within virions and subcellular localization of human immunodeficiency virus type 1 integrase
129. The karyophilic properties of human immunodeficiency virus type 1 integrase are not required for nuclear import of proviral DNA
130. Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the mu chain of adaptor complexes
131. Nuclear localization of human immunodeficiency virus type 1 integrase expressed as a fusion protein with green fluorescent protein
132. Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex
133. Viral protein R regulated nuclear import of the HIV-1 pre-integration complex
134. Reverse transcriptase fidelity and HIV-1 variation
135. cdc2-cyclin B
136. Identification and mapping of inhibitory sequences in the human immunodeficiency virus type 1 vif gene
137. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components
138. Integration of murine leukemia virus DNA depends on mitosis
139. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection
140. Identification of a binding site for the human immunodeficiency virus type 1 nucleocapsid protein
141. Cell proliferation is not required for productive HIV-1 infection of macrophages
142. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway
143. Productive HIV-1 infection of macrophages restricted to the cell fraction with proliferative capacity
144. Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest
145. Persistence of episomal HIV-1 infection intermediates in patients on highly active antiretroviral therapy
146. Gene acquisition in HIV and SIV
147. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells
148. Evidence for a newly discovered cellular anti-HIV-1 phenotype
149. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein
150. Virion incorporation of human immunodeficiency virus type-1 Vif is determined by intracellular expression level and may not be necessary for function
151. Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions
152. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes
153. Susceptibility of human monocytes to HIV type 1 infection in vitro is not dependent on their level of CD4 expression
154. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1
155. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro
156. Integration is not necessary for expression of human immunodeficiency virus type 1 protein products
157. HIV nuclear import: What's the flap?
158. Viral genens and their products
159. + cells: Mechanism for persistence in AIDS
160. HIV-1 replication is controlled at the level of T cell activation and proviral integration
161. Downregulation of cell surface molecules during noncytopathic infection of T cells with human immunodeficiency virus
162. The HIV 'A' (sor) gene product is essential for virus infectivity
163. The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix
164. Getting across the nuclear pore complex
165. Functional association of cyclophilin A with HIV-1 virions
166. HIV accessory proteins: Leading roles for the supporting case
167. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes
168. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection
169. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes
170. vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells
171. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA
172. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients
173. Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1
174. Human immunodeficiency virus type 1 interase: Effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells
175. Karyopherins and kissing cousins
176. Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 gag precursor protein
177. Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles
178. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: Role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation
179. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells
180. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells
181. A naturally immunogenic virion-associated protein specific for HIV-2 and SIV
182. The vpx gene of simian immunodeficiency virus facilitates efficient viral replication in fresh lymphocytes and macrophages
183. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
184. HIV-1 genome nuclear import is mediated by a central DNA flap
185. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells
186. Identification of a membrane-binding domain within the aminoterminal region of human immunodeficiency virus type 1 gag protein which interacts with acidic phospholipids
187. Phosphorylation of human immunodeficiency virus type 1 Vpr regulates cell cycle arrest